CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Insilico Medicine Introduces Biological Age into Virtual Cell Research: Launches Virtual Aging Cell Webpage and Previews Multi-Agent Driven VAC Generation Platform

Positive
AI Analysis

Summary

Insilico Medicine launched its Virtual Aging Cell (VAC) platform with biological age as a core parameter, building on a decade of research from NVIDIA GTC and its PreciousGPT model series. The platform is presented as the industry's first multi-agent driven VAC generation system.

Importance:3/10
Sentiment:
0.60
virtual_cellaging_biologyAI_platformresearch_toolcomputational_biology
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on August 14, 2026 1:10 PM

Read Original